Table 2.
Among Young People with Stimulant Prescriptions, Percentages with Stimulants Only, and Any Antipsychotic, Antidepressant, Mood Stabilizer, and Benzodiazepine Prescriptions by Age Group and Prescribing Physicians, United States 2008
| Age (years) | ||||
|---|---|---|---|---|
| 3–5 (%) | 6–12 (%) | 13–18 (%) | 19–24 (%) | |
| Among youth with stimulant prescriptions | ||||
| Stimulants only | 82.1 | 82.9 | 74.3 | 69.9 |
| Antipsychotics, any | 15.0 | 11.8 | 13.2 | 7.3 |
| Mood Stabilizers, any | 4.0 | 4.4 | 7.9 | 8.1 |
| Antidepressants, any | 4.1 | 7.9 | 17.5 | 23.9 |
| Anxiolytics, any | 1.1 | 0.7 | 1.8 | 8.4 |
| Among youth with stimulant prescriptions and ≥1 other psychotropic class, prescribing physicians | ||||
| Child and adolescent psychiatrists, any | 31.0 | 37.9 | 35.1 | 15.8 |
| Psychiatrists, any | 59.8 | 68.2 | 67.9 | 57.1 |
| Pediatricians, any | 28.8 | 25.5 | 18.7 | 6.3 |
| Nonpediatric primary care providers, any | 8.1 | 10.7 | 14.5 | 31.9 |
IMS LifeLink® Information Assets-LRx Longitudinal Prescription Database, 2008, IMS Health Incorporated.